ANDA 72304, held by Aiping Pharm Inc. Atenolol.
As of Nov 15, 2026, ANDA 72304 (Atenolol), held by Aiping Pharm Inc, was first approved by FDA on Jul 15, 1988, with 22 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 15, 1988 | Original application | Approved | None posted |
| Jun 7, 2002 | Supplement 25Manufacturing | Approved | None posted |
| Dec 26, 2000 | Supplement 24Manufacturing | Approved | None posted |
| Aug 2, 1999 | Supplement 23Manufacturing | Approved | None posted |
| Oct 9, 1997 | Supplement 21Manufacturing | Approved | None posted |
| Jan 29, 1997 | Supplement 22Labeling | Approved | None posted |
| May 25, 1995 | Supplement 20Manufacturing | Approved | None posted |
| Oct 18, 1994 | Supplement 19Labeling | Approved | None posted |
| Dec 16, 1993 | Supplement 18Labeling | Approved | None posted |
| Mar 10, 1993 | Supplement 17Labeling | Approved | None posted |
| Jun 18, 1992 | Supplement 16Labeling | Approved | None posted |
| Jun 18, 1992 | Supplement 15Manufacturing | Approved | None posted |
| Jun 18, 1992 | Supplement 14Manufacturing | Approved | None posted |
| Dec 6, 1991 | Supplement 13Labeling | Approved | None posted |
| Nov 8, 1990 | Supplement 12Labeling | Approved | None posted |
| Oct 1, 1990 | Supplement 11Labeling | Approved | None posted |
| Dec 15, 1989 | Supplement 10Labeling | Approved | None posted |
| Aug 14, 1989 | Supplement 5Manufacturing | Approved | None posted |
| Aug 14, 1989 | Supplement 4Labeling | Approved | None posted |
| Aug 14, 1989 | Supplement 3Manufacturing | Approved | None posted |
| Aug 14, 1989 | Supplement 2Manufacturing | Approved | None posted |
| Mar 29, 1989 | Supplement 1Manufacturing | Approved | None posted |
| Dec 15, 1988 | Supplement 6Manufacturing | Approved | None posted |
| Jul 15, 1988 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters